Acetylcysteine Effervescent Tablets

( DrugBank: Acetylcysteine / KEGG DRUG: Acetylcysteine )

1 disease

ID	Disease name (Link within this page)	Number of trials
85	Idiopathic interstitial pneumonia	8

85. Idiopathic interstitial pneumonia

Clinical trials : 627 / Drugs : 443 - (DrugBank : 120) / Drug target genes : 99 - Drug target pathways : 212

trials per page:

Showing 1 to 8 of 8 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04312594 (ClinicalTrials.gov)	September 8, 2020	27/2/2020	Jaktinib Dihydrochloride Monohydrate in Idiopathic Pulmonary Fibrosis	A Multicenter, Randomized, Double-Blind,Placebo-controlled,Phase 2 Trial of Jaktinib Dihydrochloride ...	Idiopathic Pulmonary Fibrosis	Drug: Jaktinib Dihydrochloride Monohydrate 50mg BID and Mimic tabletsof jakitinib hydrochloride 75mg ...	Suzhou Zelgen Biopharmaceuticals Co.,Ltd	NULL	Recruiting	50 Years	N/A	All	90	Phase 2	China
2	EUCTR2012-000564-14-GB (EUCTR)	11/09/2013	04/07/2013	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	Patients with Idiopathic Pulmonary Fibrosis (IPF) MedDRA version: 17.0;Level: PT;Classification code ...	Trade Name: Fluimucil® 600 mg effervescent tablets INN or Proposed INN: ACETYLCYSTEINE Other descripti ...	InterMune International AG.	NULL	Not Recruiting			Female: yes Male: yes	120	Phase 2	Belgium;Denmark;Austria;Germany;Italy;United Kingdom;Sweden
3	EUCTR2012-000564-14-DK (EUCTR)	28/08/2013	12/07/2013	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	Patients with Idiopathic Pulmonary Fibrosis (IPF) MedDRA version: 17.0;Level: PT;Classification code ...	Trade Name: Fluimucil® 600 mg effervescent tablets INN or Proposed INN: ACETYLCYSTEINE Other descripti ...	InterMune International AG.	NULL	Not Recruiting			Female: yes Male: yes	120	Phase 2	Belgium;Austria;Denmark;Germany;United Kingdom;Italy;Sweden
4	EUCTR2012-000564-14-AT (EUCTR)	19/07/2013	11/06/2013	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	Patients with Idiopathic Pulmonary Fibrosis (IPF) MedDRA version: 17.0;Level: PT;Classification code ...	Trade Name: Fluimucil® 600 mg effervescent tablets INN or Proposed INN: ACETYLCYSTEINE Other descripti ...	InterMune International AG.	NULL	Not Recruiting			Female: yes Male: yes	120	Phase 2	Belgium;Denmark;Austria;Germany;United Kingdom;Italy;Sweden
5	EUCTR2012-000564-14-DE (EUCTR)	17/07/2013	29/05/2013	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	Patients with Idiopathic Pulmonary Fibrosis (IPF) MedDRA version: 17.0;Level: PT;Classification code ...	Trade Name: Fluimucil® 600 mg effervescent tablets INN or Proposed INN: ACETYLCYSTEINE Other descripti ...	InterMune International AG.	NULL	Not Recruiting			Female: yes Male: yes	120	Phase 2	Belgium;Denmark;Austria;Germany;United Kingdom;Italy;Sweden
6	EUCTR2012-000564-14-IT (EUCTR)	17/07/2013	07/06/2013	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	Patients with Idiopathic Pulmonary Fibrosis (IPF) MedDRA version: 16.0;Level: PT;Classification code ...	Trade Name: Fluimucil® 600 mg effervescent tablets INN or Proposed INN: ACETYLCYSTEINE Other descripti ...	InterMune International AG.	NULL	Not Recruiting			Female: yes Male: yes	250	Phase 2	Belgium;Denmark;Austria;Germany;United Kingdom;Italy;Sweden
7	EUCTR2012-000564-14-SE (EUCTR)	25/06/2013	24/05/2013	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	Patients with Idiopathic Pulmonary Fibrosis (IPF) MedDRA version: 17.0;Level: PT;Classification code ...	Trade Name: Fluimucil® 600 mg effervescent tablets INN or Proposed INN: ACETYLCYSTEINE Other descripti ...	InterMune International AG.	NULL	Not Recruiting			Female: yes Male: yes	120	Phase 2	Belgium;Denmark;Austria;Germany;United Kingdom;Italy;Sweden
8	EUCTR2012-000564-14-BE (EUCTR)	18/06/2013	30/04/2013	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	Patients with Idiopathic Pulmonary Fibrosis (IPF) MedDRA version: 17.0;Level: PT;Classification code ...	Trade Name: Fluimucil® 600 mg effervescent tablets INN or Proposed INN: ACETYLCYSTEINE Other descripti ...	InterMune International AG.	NULL	Not Recruiting			Female: yes Male: yes	120	Phase 2	Belgium;Denmark;Austria;Germany;United Kingdom;Italy;Sweden

First Previous1Next Last